Alzheimer's Disease - HealthQuill

Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer's disease, and these abnormal proteins also accumulate in the dying cells in the retina of the eyes of the patients with the condition, investigators at Cedars-Sinai Medical Center found.

Abnormal protein accumulation in patient’s eyes linked to Alzheimer’s

HQ Team March 4, 2025: Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer’s disease, and these.

by HealthQuill
March 4, 2025
0 Comments

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according to a company statement.

Health Medical Pharma

Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.

by HealthQuill
February 24, 2025
0 Comments

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

by HealthQuill
January 31, 2025
0 Comments

GLP-1 based weight-loss drugs have some therapeutic benefits, but the risks are as high

Drugs Pharma Research

New insights on GLP-1 drugs: Benefits and risks unveiled

HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their.

by HealthQuill
January 21, 2025
0 Comments

Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of 30%, according to a Securities and Exchange Commission filing.

Drugs Medical Pharma

Biogen Inc., to buy 62m outstanding shares of Sage for $441.7 million

Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of.

by HealthQuill
January 11, 2025
0 Comments

Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets to treat high blood pressure.

Health Medical

Sleeping pills show promise in reducing Alzheimer’s proteins

HQ Team December 28, 2024: Research has shown a potential connection between the progression of Alzheimer’s disease in people who take sleeping pills..

by HealthQuill
December 27, 2024
0 Comments

Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous treatments.

Health Medical

Taxi and ambulance drivers may have lower Alzheimer’s risk, study finds

HQ Team December 18, 2024: Taxi and ambulance drivers may have a lower risk of dying from Alzheimer’s disease compared to many other.

by HealthQuill
December 18, 2024
0 Comments

Drugs Pharma

Breakthrough in halting dementia progression found by biotech company

HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,.